Search For "pfizer"
In talks with manufacturers regarding vaccine logistics: Centre
Updated : 5 years, 4 months ago IST
New Delhi [India], November 10 (ANI): A day after Pfizer Inc and BioNTech SE announced around 90 per cent efficacy of their COVID-19 vaccine in their ongoing phase three trial, the central government on Tuesday said that it is in dialogue with both the domestic and international vaccine manu
Read More
End of fight against Covid-19 still months away, says Biden on Pfizer's va
Updated : 5 years, 4 months ago IST
Washington [US], November 10 (ANI): US President-elect Joe Biden on Monday said that Pfizer's announcement that a Covid-19 vaccine it was developing was 90 per cent effective, offered cause for hope but warned that the battle ahead was still long.
Read More
Pfizer says its coronavirus vaccine more than 90 pc effective in first ana
Updated : 5 years, 4 months ago IST
Washington [US], November 9 (ANI): The coronavirus vaccine developed by drug giant American Pfizer and German biotechnology firm BioNTech was more than 90 per cent effective at protecting people from infection as compared to placebo saline shot, according to an analysis.
Read More
Australia signs COVID-19 vaccine deals with Novavax, Pfizer
Updated : 5 years, 4 months ago IST
Canberra [Australia], November 5 (ANI/Sputnik): The Australian government has signed agreements on Thursday with pharmaceutical company Novavax and a consortium of companies, Pfizer and BioNTech, to supply 50 million doses of COVID-19 vaccines.
Read More
AstraZeneca CEO says COVID-19 vaccine may be ready by end of year despite
Updated : 5 years, 6 months ago IST
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Read More
US to pay Pfizer, BioNTech $1.95 billion for 100 million doses of Covid-19
Updated : 5 years, 8 months ago IST
Washington D.C. [US], July 23 (ANI): The U.S. has agreed to pay Pfizer and BioNTech SE nearly $2 billion to secure 100 million doses of their experimental Covid-19 vaccine to provide to Americans free of charge, reported The Wall Street Journal.
Read More
UK signs deals to buy 90 million doses of two coronavirus vaccine candidat
Updated : 5 years, 8 months ago IST
London [UK], July 20 (ANI): The UK government has signed agreements to buy 90 million doses of two promising COVID-19 vaccine candidates.
Read More
Equity indices up on vaccine hopes, banking and financial stocks gain
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 2 (ANI): Equity benchmark indices were up by nearly one per cent during early hours on Thursday tracking gains in Asian peers as investors hoped of a vaccine for COVID-19.
Read More
Govts, drugmakers under pressure to roll out effective COVID vaccines
Updated : 5 years, 10 months ago IST
Washington D.C. [USA], May 18 (ANI): Governments and drugmakers are considering ways how to roll out effective coronavirus vaccines and build capacity to make millions of its doses available in the United States starting as soon as this fall. Yet there isn't a guarantee that any of the most
Read More
Potential coronavirus vaccine enters human testing in US
Updated : 5 years, 10 months ago IST
Washington [US], May 06 (ANI): United States-based pharmaceutical giant Pfizer has begun testing multiple versions of an experimental vaccine in healthy young people in America.
Read More
Biocon Biologics expands R&D footprint by acquiring assets of Pfizer Healt
Updated : 6 years, 6 months ago IST
Bengaluru (Karnataka) [India], Sep 24 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday that its subsidiary has acquired research and development capital assets from Pfizer Healthcare India Ltd.
Read More
SEBI imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading
Updated : 6 years, 6 months ago IST
Mumbai (Maharashtra) [India], Sep 24 (ANI): The Securities Exchange Board of India (SEBI) has imposed penalties of Rs 22.7 crore on Aurobindo Pharma, its related entities and promoters for violating insider trading rules with respect to a licensing deal it had entered with Pfizer in 2009.
Read More